Որոնման արդյունքները - Muhammad Alamgeer
- Ցուցադրվում են 1 - 9 արդյունքները 9
-
1
The Evolution of Therapies in Non-Small Cell Lung Cancer Vishal Boolell, Muhammad Alamgeer, D. Neil Watkins, Vinod Ganju
Հրապարակվել է 2015Revisão -
2
-
3
Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study Muhammad Alamgeer, Ryan Ruiyang Ling, Ryo Ueno, Krishnaswamy Sundararajan, Raghav Sundar, David Pilcher, Ashwin Subramaniam
Հրապարակվել է 2023Artigo -
4
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer Muhammad Alamgeer, Vinod Ganju, Beena Kumar, Jane Fox, Stewart Hart, Michelle White, Marion Harris, John Stuckey, Zdenka Prodanovic, Michal Schneider, D. Neil Watkins
Հրապարակվել է 2014Artigo -
5
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer Muhammad Alamgeer, Vinod Ganju, Anette Szczepny, Prudence A. Russell, Zdenka Prodanovic, Beena Kumar, Zoe Wainer, Tracey J. Brown, Michal Schneider, Matthew Conron, Gavin Wright, D. Neil Watkins
Հրապարակվել է 2013Artigo -
6
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors Andrea Muscat, Dean Popovski, W. Samantha N. Jayasekara, Fernando J. Rossello, Melissa Ferguson, Kieren D. Marini, Muhammad Alamgeer, Elizabeth M. Algar, Peter Downie, D. Neil Watkins, Jason E. Cain, David M. Ashley
Հրապարակվել է 2016Artigo -
7
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat Jasmine Chen, Aleks C. Guanizo, W. Samantha N. Jakasekara, Chaitanya Inampudi, Quinton Luong, Daniel J. Garama, Muhammad Alamgeer, Nishant Thakur, Michael DeVeer, Vinod Ganju, D. Neil Watkins, Jason E. Cain, Daniel J. Gough
Հրապարակվել է 2023Artigo -
8
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study Luke S. McLean, Annette M. Lim, Mathias Bressel, Jenny Lee, Rahul Ladwa, Alexander Guminski, Brett Hughes, Samantha Bowyer, Karen Briscoe, S.J. Harris, Craig Kukard, Robert Zielinski, Muhammad Alamgeer, Matteo S. Carlino, Jeremy Mo, John Park, Muhammad A. Khattak, Fiona Day, Danny Rischin
Հրապարակվել է 2024Artigo -
9
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy Kieren D. Marini, David R. Croucher, Rachael A. McCloy, Vijesh Vaghjiani, Álvaro González-Rajal, Jordan F. Hastings, Venessa Chin, Anette Szczepny, Kaja Kostyrko, César Márquez, W. Samantha N. Jayasekara, Muhammad Alamgeer, Vishal Boolell, Jeremy Z. R. Han, Todd Waugh, Hong Ching Lee, Samantha R. Oakes, Beena Kumar, Craig A. Harrison, Mark P. Hedger, Nirmal Lorensuhewa, Badia Kita, Ross Barrow, Bruce Robinson, David M. de Kretser, Jianmin Wu, Vinod Ganju, E. Alejandro Sweet‐Cordero, Andrew Burgess, Luciano G. Martelotto, Fernando J. Rossello, Jason E. Cain, D. Neil Watkins
Հրապարակվել է 2018Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Cancer
Internal medicine
Cancer research
Biochemistry
Biology
Oncology
Gene
Chemotherapy
Lung cancer
Pathology
Retrospective cohort study
Adenocarcinoma
Aldehyde dehydrogenase
Breast cancer
Cancer stem cell
Catalysis
Cell biology
Cohort
Genetics
Immunology
Immunotherapy
Paleontology
Platinum
Proportional hazards model
Anaplastic lymphoma kinase
Apoptosis
Art
Atypical teratoid rhabdoid tumor
CD44